BioPartners has extensive experience executing infectious disease studies, including diagnostic validation programs, respiratory and non-respiratory multi-swab studies, comparative device performance evaluations, and large-scale biospecimen procurement.

We support studies involving viral, bacterial, and fungal pathogens, offering controlled workflows for swab collection, blood draws, stool samples, saliva, and other specimen types. Our teams adhere to strict biosafety protocols and standardized sample-handling procedures designed to maintain the stability, accuracy, and reliability of sensitive analytes.

Our infectious disease capabilities are strengthened by access to diverse symptomatic and asymptomatic populations, enabling efficient enrollment for studies requiring matched swabs, serial sampling, or seasonally dependent recruitment. We work closely with sponsors developing point-of-care tests, molecular assays, multiplex platforms, and rapid diagnostics.

BioPartners’ infrastructure ensures accurate labeling, temperature-controlled transport, adherence to IATA regulations, and seamless communication throughout the study lifecycle.

Our operational expertise produces high-quality results that support assay validation, regulatory submissions, and large commercial diagnostic launches.

BioPartners supports a broad spectrum of oncology research, covering both solid tumors and hematologic malignancies. Our capabilities span IVD/device performance studies, biomarker-driven clinical trials, observational programs, and precision-medicine initiatives that require high-quality, well-characterized biospecimens.

We specialize in collecting and processing samples essential for genomic profiling, immunohistochemistry, next-generation sequencing, ctDNA analysis, and emerging liquid biopsy technologies. Our integrated CRO + clinical site model ensures the highest level of protocol adherence and quality oversight, providing sponsors with detailed clinical annotations and consistent, reproducible datasets.

Our clinical teams are trained to support complex oncology workflows, including multi-timepoint sampling, matched biospecimen procurement, temperature-controlled chain-of-custody management, and real-time documentation. With access to diverse patient populations across California and Eastern Europe, we accelerate oncology enrollment and generate robust datasets that strengthen diagnostic validation efforts and therapeutic development.

BioPartners is committed to advancing personalized oncology by ensuring that every biospecimen, every data point, and every study element reflects scientific rigor and operational excellence.

Beyond our key focus areas, BioPartners supports a wide range of additional therapeutic fields, including neurology, immunology, hepatology, gastroenterology, rare diseases, and niche diagnostic indications.

Our flexible operational infrastructure allows rapid study start-up and adaptation to specialized workflows.

We provide:

• Customized biospecimen collection
• Study-specific protocol execution
• Specialized sample processing methods
• Access to unique and diverse patient populations
• Robust quality oversight across all procedures

Whether your study requires complex sample handling, multi-site coordination, or rare-disease recruitment, BioPartners is equipped to deliver consistent, high-quality results.

Whether you’re a sponsor seeking a high-performing research partner or a patient interested in participating, BioPartners is committed to excellence, ethics, and innovation in every project we support.